
Opinion|Videos|October 29, 2024
Combination Approach in Photodynamic Therapy
Author(s)Ted Lain, MD, MBA, FAAD
Ted Lain, MD, MBA, FAAD, discusses how a combination approach in photodynamic therapy integrates multiple treatment modalities or agents to enhance therapeutic efficacy and overcome limitations of standalone photodynamic treatments for various cancers and other diseases.
Advertisement
Episodes in this series

Advertisement
Related to this article

Pediatric dermatologists outline how to evaluate suspected topical steroid withdrawal, exclude mimics, and preserve family trust in eczema care.

Diego Ruiz Dasilva, MD, and Lindsey Finklea, MD, discuss the burden of chronic inducible urticaria and phase 3 REMIND findings for remibrutinib.

Doral Fredericks, PharmD, MBA, discusses how life stages, mental health, and reproductive concerns can shape dermatologic care for women.

Gaurav Singh, MD, explains how pharmacokinetics, trial design, and real-world tolerability set sonidegib apart from vismodegib in locally advanced basal cell carcinoma and when to start systemic therapy earlier.

Explore the top headlines of the month, including insights on the latest clinical trials, therapeutic updates, and more.

From “Botox in a bottle” to castor oil and face taping, Dermatology Times reviews the evidence behind 3 viral dermatology trends from October.
Advertisement
Advertisement
Trending on Dermatology Times
1
Women’s Health Needs in Psoriasis and Atopic Dermatitis
2
Don't Be Rash: Navigating Topical Steroid Withdrawal Concerns in Pediatric Eczema
3
Systemic Therapy Selection in Pediatric and Adult Atopic Dermatitis
4
Between the Lines: Remibrutinib and the Evolving CIndU Treatment Landscape
5








